ikcs 2020: session 3 immunotherapy and emerging therapies for rcc
Published 3 years ago • 58 plays • Length 1:33:22Download video MP4
Download video MP3
Similar videos
-
50:08
ikcs 2020: non-clear cell rcc session
-
1:01:19
ikcs 2020: session 1: multimodality therapy for locally advanced rcc
-
2:09:09
ikcs 2020: session 5: multimodality therapy for metastatic rcc
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
1:25:04
#kcrs20: emerging biomarkers for kidney cancer
-
1:17:43
kcrs24 session six: immunotherapy advances in kidney cancer | kidneycan
-
3:05
emerging therapies for advanced kidney cancer
-
1:10:11
ikcs 2020 top abstracts session
-
0:48
will immunotherapy take over the treatment landscape of patients high-risk renal cell carcinoma?
-
1:59:34
aua2019 023ic: chemotherapy and immunotherapy options for genitourinary malignancies
-
0:41
what's the difference between cancer stage and fuhrman grade?
-
0:35
potential of immunotherapy for kidney cancer
-
1:38:51
clinically meaningful outcomes among expanding treatment options in rcc
-
10:55
ikcs 2020: phase 2 trial of lenvatinib at 2 starting doses everolimus in renal cell carcinoma (rcc)
-
5:16
potential new treatments in renal cell carcinoma
-
0:50
emerging role of adjuvant immunotherapy in oncology
-
29:11
new data and clinical context: an update on renal cell carcinoma care